Volume 9, Number 3 October 2010 - World Psychiatric Association

Reward processing after catecholamine de 鄄pletion in unmedicated, remitted subjectswith major depressive disorder. Biol Psychi 鄄atry 2009; 66 颐 201-5.57. Murphy FC, Michael A, Robbins TW et al.Neuropsychological impairment in patientswith major depressive disorder: the effectsof feedback on task performance. PsycholMed 2003; 33 颐 455-67.58. Mann JJ. The medical management of de 鄄pression. N Engl J Med 2005; 353 颐 1819-34.59. Fava M, Thase ME, DeBattista C. A mul 鄄ticenter, placebo - controlled study ofmodafinil augmentation in partial respondersto selective serotonin reuptake inhibitors withpersistent fatigue and sleepiness. J ClinPsychiatry 2005; 66 颐 85-93.60. Simpson D. Phrenology and the neuro 鄄sciences: contributions of F. J. Gall andJ. G. Spurzheim. ANZ J Surg 2005; 75 颐475-82.61. Fitzgerald PB, Laird AR, Maller J et al. Ameta-analytic study of changes in brain acti 鄄vation in depression. Hum Brain Mapp2008; 29 颐 683-95.62. Koolschijn PC, van Haren NE, Lensvelt -Mulders GJ et al. Brain volume abnormali 鄄ties in major depressive disorder: a meta 鄄analysis of magnetic resonance imaging stud 鄄ies. Hum Brain Mapp 2009; 30 颐 3719-35.63. Rajkowska G, Miguel-Hidalgo JJ, Wei J etal. Morphometric evidence for neuronal andglial prefrontal cell pathology in major de 鄄pression. Biol Psychiatry 1999; 45 颐 1085-98.64. Hercher C, Turecki G, Mechawar N.Through the looking glass: examining neuro 鄄anatomical evidence for cellular alterations inmajor depression. J Psychiatr Res 2009; 43颐 947-61.65. Price JL, Drevets WC. Neurocircuitry ofmood disorders. Neuropsychopharmacology2009; 35 颐 192-216.66. Damasio AR, Tranel D, Damasio H. Indi 鄄viduals with sociopathic behavior caused byfrontal damage fail to respond autonomicallyto social stimuli. Behav Brain Res 1990; 41颐 81-94.67. Sullivan RM, Gratton A. Lateralized effectsof medial prefrontal cortex lesions on neuro 鄄endocrine and autonomic stress responses inrats. J Neurosci 1999; 19 颐 2834-40.68. Mayberg HS, Lozano AM, Voon V et al.Deep brain stimulation for treatment-resist 鄄ant depression. Neuron 2005; 45 颐 651-60.69. MacQueen GM. Magnetic resonance imagingand prediction of outcome in patients withmajor depressive disorder. J PsychiatryNeurosci 2009; 34 颐 343-9.70. Kessing LV, Hansen MG, Andersen PK etal. The predictive effect of episodes on therisk of recurrence in depressive and bipolardisorders-a life-long perspective. Acta Psy 鄄chiatr Scand 2004; 109 颐 339-44.71. Sheline YI, Gado MH, Kraemer HC Un 鄄treated depression and hippocampal volumeloss. Am J Psychiatry 2003; 160 颐 1516-8.72. Hasler G, Fromm S, Alvarez RP et al.Cerebral blood flow in immediate and sus 鄄tained anxiety. J Neurosci 2007; 27 颐 6313-9.73. Frodl TS, Koutsouleris N, Bottlender R etal. Depression - related variation in brainmorphology over 3 years: effects of stress?Arch Gen Psychiatry 2008; 65 颐 1156-65.74. Martinowich K, Manji H, Lu B. New in 鄄sights into BDNF function in depression andanxiety. Nature Neurosci 2007; 10 颐 1089-93.75. Hasler G, van der Veen JW, Tumonis T etal. Reduced prefrontal glutamate/ glutamineand gamma-aminobutyric acid levels in ma 鄄jor depression determined using proton mag 鄄netic resonance spectroscopy. Arch GenPsychiatry 2007; 64 颐 193-200.76. Hasler G, van der Veen JW, Grillon C etal. Effect of acute psychological stress onprefrontal gamma-aminobutyric acid concen 鄄tration determined by proton magnetic reso 鄄nance spectroscopy. Am J Psychiatry ( inpress).77. Rajkowska G, O 蒺 Dwyer G, Teleki Z et al.GABAergic neurons immunoreactive for cal 鄄cium binding proteins are reduced in theprefrontal cortex in major depression. Neu 鄄ropsychopharmacology 2007; 32 颐 471-82.78. Eser D, Schule C, Baghai TC et al. Neu 鄄roactive steroids in depression and anxietydisorders: clinical studies. Neuroendocri 鄄nology 2006; 84 颐 244-54.79. Birkenhager TK, Moleman P, Nolen WA.Benzodiazepines for depression? A review ofthe literature. Int Clin Psychopharmacol1995; 10 颐 181-95.80. Hasler G, Neumeister A, van der Veen JWet al. Normal prefrontal gamma - aminobu 鄄tyric acid levels in remitted depressed sub 鄄jects determined by proton magnetic reso 鄄nance spectroscopy. Biol Psychiatry 2005;58 颐 969-73.81. Zarate CA, Jr. , Singh JB, Carlson PJ etal. A randomized trial of an N-methyl-Daspartateantagonist in treatment - resistantmajor depression. Arch Gen Psychiatry2006; 63 颐 856-64.82. Kendell SF, Krystal JH, Sanacora G. GA 鄄BA and glutamate systems as therapeutic tar 鄄gets in depression and mood disorders. Ex 鄄pert Opin Ther Targets 2005; 9 颐 153-68.83. Feyissa AM, Chandran A, Stockmeier CAet al. Reduced levels of NR2A and NR2Bsubunits of NMDA receptor and PSD-95 inthe prefrontal cortex in major depression.Prog Neuropsychopharmacol Biol Psychiatry2009; 33 颐 70-5.84. Deschwanden A, Hasler G. Metabotropicglutamate receptor 5: role in depression?Presented at the 22nd European College ofNeuropsychopharmacology Meeting, Istan 鄄bul, May 2009.85. Bunney WE, Bunney BG. Molecular clockgenes in man and lower animals: possibleimplications for circadian abnormalities indepression. Neuropsychopharmacology2000; 22 颐 335-45.86. Boivin DB, Czeisler CA, Dijk DJ et al.Complex interaction of the sleep-wake cycleand circadian phase modulates mood inhealthy subjects. Arch Gen Psychiatry 1997;54 颐 145-52.87. Germain A, Kupfer DJ. Circadian rhythmdisturbances in depression. Hum Psycho 鄄pharmacol 2008; 23 颐 571-85.88. Duncan WC, Jr. Circadian rhythms and thepharmacology of affective illness. PharmacolTher 1996; 71 颐 253-312. Psychiatry 1999;156 颐 675-82.摇 161